Advanced myelin-related MRI measures in relapsing multiple sclerosis patients treated with ocrelizumab or interferon beta-1a over 96 weeks

Authors
Category Primary study
JournalNeurology
Year 2017
This article has no abstract
Epistemonikos ID: 40fa74aadd4c8e9c0c9cd35be15661bc4ab87934
First added on: Feb 08, 2025